Participant survey

Pigmented lesions of the eye may transform into melanoma and when this occurs, the disease can spread systemically, with death occasionally occurring within a year. A nationwide study on pigmented/melanocytic lesions of the eye in Aotearoa/New Zealand will be conducted in 2022 with the ultimate aim of streamlining and improving the referral process for pigmented lesions concerning for ocular melanoma. We plan to utilise telemedicine to facilitate early diagnosis, timely commencement of ocular melanoma treatment where appropriate, and regular reviews.  The participation of all NZ optometrists is absolutely vital to the success of this nationwide study and to recognise your participation, we will be providing regular study feedback and be offering CPD points.

We appreciate your time in filling out this market survey to indicate your interest/availability for this study and welcome any feedback below. We will contact you directly with more information before the start date of the study.

Please contact Joevy.lim@auckland.ac.nz if you have any questions.

Question Title

* 1. Will you be interested in participating in our study?

Question Title

* 2. Practitioner Full Name:

Question Title

* 3. Name of Practice:

Question Title

* 4. Practitioner Role:

Question Title

* 6. Please provide your e-mail below so that we can get in contact when the study commences.

Question Title

* 7. Please indicate the availability of the following ophthalmic devices at your practice

Question Title

* 8. Would you prefer to have a 2-page online or physical copy of the referral form to complete (takes approximately 5 minutes to fill)?

Question Title

* 9. Do you have any questions or recommendations you would like to share regarding this study?

Thank you very much for filling in this form and for your feedback. We will be in touch shortly, watch this space!

T